Substance / Medication

Neomycin

Overview

Active Ingredient
neomycin
RxNorm CUI
7299

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

4 trials linked to this intervention

4
Total Trials
2
Recruiting
1
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Prevalence of Contact Allergy to Neomycin in Dermatitis Patients: A Systematic Review and Meta-Analysis.
Jensen Mikkel Bak, Isufi Daniel, Larsen Christoffer Kursawe et al. · Contact Dermatitis · 2025
PMID: 40107276Meta-AnalysisFull text (PMC)
Erythromycin versus neomycin in the treatment of hepatic encephalopathy in cirrhosis: a randomized double-blind study.
Romeiro Fernando Gomes, da Silva Yamashiro Fabio, Américo Madileine Francely et al. · BMC Gastroenterol · 2013
PMID: 23324408RCTFull text (PMC)
Ofloxacin otic drops vs neomycin-polymyxin B otic drops as prophylaxis against early postoperative tympanostomy tube otorrhea.
Poetker David M, Lindstrom D Richard, Patel Nalin J et al. · Arch Otolaryngol Head Neck Surg · 2006
PMID: 17178938RCT
Prevalence and Determinants of Sensitisation to Neomycin in North-Eastern Italy, 1997-2021.
Cegolon Luca, Larese Filon Francesca, [object Object] · Contact Dermatitis · 2025
PMID: 39778913ObservationalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Neomycin (substance)
SNOMED CT
373528008
UMLS CUI
C0027603
RxNorm CUI
7299

Clinical Data

This intervention maps to 5 entities in the Ltrl knowledge graph.

5
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
4
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.